Charts Newron Pharmaceuticals S.p.A. Deutsche Boerse AG
Stocks
NP5
IT0004147952
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
02:05:42 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 13.30 EUR | +3.50% |
|
-0.37% | -50.09% |
| 07-03 | Newron Pharmaceuticals to Make Changes to Phase 3 Trial of Schizophrenia Treatment | MT |
| 05-05 | Edison Is Not Overly Concerned About a Trial Suspension |  |
Chart: Technical Analysis
Stock exchange
Deutsche Boerse AG
NP5 13.30 €
+3.50%
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Swiss Exchange
| NWRN | 12.36CHF | -1.90% | 379K CHF | |
CBOE
| 0QOI | 12.30CHF | -1.76% | 45.74K CHF | |
|
Tradegate
| NP5 | 13.15EUR | -2.59% | 15.45K € | |
|
Xetra
| NP5 | 13.20EUR | -1.86% | 10.05K € | |
|
Boerse Muenchen
| NP5 | 13.20EUR | -1.86% | 9.75K € | |
|
Deutsche Boerse AG
| NP5 | 13.30EUR | +3.50% | 0 € | |
|
Börse Stuttgart
| NP5 | 13.10EUR | -2.60% | 0 € |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NWRN Stock
- NP5 Stock
- Charts Newron Pharmaceuticals S.p.A.
Select your edition
All financial news and data tailored to specific country editions
